awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33607736-34DBC1C8-AB58-40A1-8C24-41268CB419F6
Q33607736-34DBC1C8-AB58-40A1-8C24-41268CB419F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33607736-34DBC1C8-AB58-40A1-8C24-41268CB419F6
Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.
P2860
Q33607736-34DBC1C8-AB58-40A1-8C24-41268CB419F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33607736-34DBC1C8-AB58-40A1-8C24-41268CB419F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
01159728df17178e3e258a694b090a5cbf7fbfaa
P2860
Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.